Clinical and regulatory intelligence for Skin Disorders with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Assets: 1

Relevant assets

GDS-23 →

Relevant companies

No related entities indexed yet.

Recent signals(1)

StrategyJuly 15, 2026

GDS-23 Niosomes Enhance Vitamin C Delivery and Antioxidant Uptake in Skin

GDS-23 niosomes enhance transdermal delivery of vitamin C by inducing SVCT2 and upregulating antioxidant transporters.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Dermatology →

Skin Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.